Detection and quantification of the parenchymal abnormalities in emphysema using pulmo-CT

dc.contributor.authorTemizoz, Osman
dc.contributor.authorEtlik, Omer
dc.contributor.authorSakarya, Mehmet Emin
dc.contributor.authorUzun, Kursat
dc.contributor.authorArslan, Halil
dc.contributor.authorHarman, Mustafa
dc.contributor.authorDemir, Mustafa Kemal
dc.date.accessioned2020-03-26T17:17:11Z
dc.date.available2020-03-26T17:17:11Z
dc.date.issued2007
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractWe aimed to determine the degree and extent of parenchymal abnormalities on pulmo-CT in patients with emphysema. The study group consisted of 29 patients (18 male, I I female; mean age 57.9. L 13). The diagnosis was based on clinical symptoms, pulmonary function tests (PFT) values, and chest CT findings. All of the patients CT scans were obtained during suspended deep inspiration from the apices to the costophrenic angles. The mean lung attenuation (MLD) and parenchymal abnormalities related to emphysema were quantitatively calculated with tables, histograms and graphics at the whole lung. The lung density measurements revealed a mean density of -898.48 +/- 51.37 HU in patients with emphysema and -825.1 +/- 25.5 HU in control group. In addition, mean percentage of subthreshold attenuation values was found as 12.03 +/- 15.75 and 1.07 +/- 0.83 in patients with emphysema and control group, respectively. Compared with control group, the patients with emphysema had a significantly lower inspiratory MLD (p < 0.05). Additionally, statistically significant correlations were seen between the MLD and percentage of subthreshold values (r = 0.44, p < 0.05). In contrast, there was poor correlation between PFT measurements and the subthreshold values. In conclusion, pulmo-CT is a quick, simple method for quantitative confirmation of the presence of parenchymal abnormalities of lung as mosaic attenuation and should be used in combination with other radiological methods and PFT as it gives additional information to routine examinations in patients with emphysema. (c) 2007 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.compmedimag.2007.06.003en_US
dc.identifier.endpage548en_US
dc.identifier.issn0895-6111en_US
dc.identifier.issue7en_US
dc.identifier.pmid17689224en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage542en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.compmedimag.2007.06.003
dc.identifier.urihttps://hdl.handle.net/20.500.12395/21302
dc.identifier.volume31en_US
dc.identifier.wosWOS:000249863800008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDen_US
dc.relation.ispartofCOMPUTERIZED MEDICAL IMAGING AND GRAPHICSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectemphysemaen_US
dc.subjectparenchymal abnormalitiesen_US
dc.subjectmosaic attenuationen_US
dc.subjectMDCTen_US
dc.subjectpulmo-CTen_US
dc.subjectquantificationen_US
dc.titleDetection and quantification of the parenchymal abnormalities in emphysema using pulmo-CTen_US
dc.typeArticleen_US

Dosyalar